Cargando…
Human P2X7 Receptor Causes Cycle Arrest in RPMI-8226 Myeloma Cells to Alter the Interaction with Osteoblasts and Osteoclasts
Multiple myeloma is a malignant expansion of plasma cells and aggressively affects bone health. We show that P2X7 receptor altered myeloma growth, which affects primary bone cells in vitro. Expression on six human myeloma cell lines confirmed the heterogeneity associated with P2X7 receptor. Pharmaco...
Autores principales: | Agrawal, Ankita, S. Kruse, Lars, J. Vangsted, Annette, Gartland, Alison, R. Jørgensen, Niklas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7690412/ https://www.ncbi.nlm.nih.gov/pubmed/33105696 http://dx.doi.org/10.3390/cells9112341 |
Ejemplares similares
-
The Mitochondria-Independent Cytotoxic Effect of Leflunomide on RPMI-8226 Multiple Myeloma Cell Line
por: Adamczuk, Grzegorz, et al.
Publicado: (2021) -
Activation of murine 'T' lymphomas in the presence of a human myeloma cell line, RPMI-8226, in vivo.
por: Millar, B. C., et al.
Publicado: (1988) -
Abnormal cytokine production by bone marrow stromal cells of multiple myeloma patients in response to RPMI8226 myeloma cells
por: Zdzisińska, Barbara, et al.
Publicado: (2008) -
Role and Mechanism of circ_0058063/miR-635 Axis in the Malignant Phenotype of Multiple Myeloma RPMI8226 Cells
por: Li, Xiaoya, et al.
Publicado: (2021) -
Engagement of CD99 Reduces AP-1 Activity by Inducing BATF in the Human Multiple Myeloma Cell Line RPMI8226
por: Gil, Minchan, et al.
Publicado: (2015)